Oligomeric amyloid-β induces early and widespread changes to the proteome in human iPSC-derived neurons

Sci Rep. 2020 Apr 16;10(1):6538. doi: 10.1038/s41598-020-63398-6.

Abstract

Alzheimer's disease (AD) is the most common form of dementia globally and is characterized by aberrant accumulations of amyloid-beta (Aβ) and tau proteins. Oligomeric forms of these proteins are believed to be most relevant to disease progression, with oligomeric amyloid-β (oAβ) particularly implicated in AD. oAβ pathology spreads among interconnected brain regions, but how oAβ induces pathology in these previously unaffected neurons requires further study. Here, we use well characterized iPSC-derived human neurons to study the early changes to the proteome and phosphoproteome after 24 h exposure to oAβ 1-42. Using nLC-MS/MS and label-free quantification, we identified several proteins that are differentially regulated in response to acute oAβ challenge. At this early timepoint, oAβ induced the decrease of TDP-43, heterogeneous nuclear ribonucleoproteins (hnRNPs), and coatomer complex I (COPI) proteins. Conversely, increases were observed in 20 S proteasome subunits and vesicle associated proteins VAMP1/2, as well as the differential phosphorylation of tau at serine 208. These changes show that there are widespread alterations to the neuronal proteome within 24 h of oAβ uptake, including proteins previously not shown to be related to neurodegeneration. This study provides new targets for the further study of early mediators of AD pathogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloid beta-Peptides / toxicity*
  • Down-Regulation / drug effects
  • Humans
  • Induced Pluripotent Stem Cells / pathology*
  • Mutation / genetics
  • Neurons / drug effects
  • Neurons / metabolism*
  • Phosphoproteins / metabolism
  • Phosphorylation / drug effects
  • Phosphoserine / metabolism
  • Protein Multimerization*
  • Protein Processing, Post-Translational / drug effects
  • Proteome / metabolism*
  • Tandem Mass Spectrometry
  • Up-Regulation / drug effects
  • tau Proteins / metabolism

Substances

  • Amyloid beta-Peptides
  • Phosphoproteins
  • Proteome
  • tau Proteins
  • Phosphoserine